INSULIN-OLIGOMER CONJUGATES, PREPARATIONS AND APPLICATIONS THEREOF Russian patent published in 2014 - IPC C07K14/62 A61K38/28 A61P3/10 

Abstract RU 2527893 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: group of inventions refers to biotechnology and can be used in producing insulin preparations for therapeutic applications. What is presented is a complex of a conjugate of insulin with a bivalent cation of a group II metal or a transient metal, wherein insulin is conjugated with a modifying group: -X-R1-Y-PAG-Z-R2 (IV), wherein: X, Y and Z represents independently the chosen binding groups and each of them optionally presents, and X, if presents, is bound to the compound insulin by a covalent bond, wherein X, Y, Z can be independently specified in -S-, -O-, -NH- and -C(O)-; at least one of R1 or R2 presents and represents lower alkyl optionally containing a carbonyl group, and provide R1 represents lower alkyl, then R2 represents a blocking group specified in -CH3, -H, tosylate or -C(O)OH; PAG represents a linear or branched carbon chain containing one or more PEG groups containing 2 to 10 of (CH2CH2O)-subunits, and optionally containing one or more additional groups specified in-S-, -O-, -NH- and -C(O)-; and wherein the modifying group has the maximum number of 3 to 25 heavy atoms specified in C, S, N and O, and bound to lysine in a position specified in a group consisting of the positions B26, B27, B28, B29 and B30 insulin within 5 amino acids of C-terminal of B-chain, thereby producing a monoconjugate. The conjugate of insulin is the same or more soluble than the respective non-conjugated insulin, and water solubility of the conjugate of insulin is reduced by adding zinc. The inventions also involve a method for preparing these complexes, pharmaceutical compositions for treating insulin deficiency in a human, containing these complexes and using them in preparing a drug for treating diabetes.

EFFECT: prepared complexes show improved chemical stability as compared to the conjugates of insulin not in the complex.

51 cl, 42 dwg, 40 tbl, 86 ex

Similar patents RU2527893C2

Title Year Author Number
INSULIN-OLIGOMER CONJUGATES, PREPARATIONS AND USE THEREOF 2005
  • Radkhakrishnan Balasingam
  • Aggarval Diti
  • Ferro Mishel'
  • Dzhejms Kennet D.
  • Malkar Navdip B.
  • Miller Mark A.
  • Pavliv Leo
  • Polovi Karen
  • Puskas Karen
  • Ehkvuribe Nnochiri N.
RU2393168C2
IMPROVED CHELATE CONJUGATES 2002
  • Archer Kolin Mill
  • Uodsvort Garri Dzhon
  • Ehngell Torgrim
RU2298012C2
SOLID PHARMACEUTICAL COMPOSITION (VERSIONS) AND METHOD FOR CONTROLLING GLUCOSE CONCENTRATION THEREWITH, METHOD FOR PREPARING SOLID PHARMACEUTICAL COMPOSITIONS (VERSIONS), TABLET (VERSIONS) AND METHOD FOR MAKING AMORPHOUS PARTICLES 2008
  • Dave Nitesh
  • Jer Kharish
  • Kkhedkar Anand
  • Melarkode Ramakrishnan
  • Murtkhi Shanmugam Tkhandava
  • Paj Kharish Venkatraman
  • Radkhakrishnan Davesh
  • Ramakrishna Randzhitkh
  • Rangappa Sharatkh Kumar Mallapura
  • Sendzhupta Nilandzhan
  • Subramani Ramesh
  • Chivukula Sudkheer
  • Shankar Sundaresh
RU2453332C2
IMPROVED CONJUGATES N4 OF CHELATING AGENTS 2005
  • Stori Ehntoni Ehjmonn
  • Uodsvort Garri
  • Pauehll Najdzhel Ehntoni
  • Dunkanson Filip
RU2360701C2
LONG-ACTING INSULIN COMPOSITION 2010
  • Sprogee Kennett
  • Kleemann Feliks
  • Kherzel' Ul'Rikh
  • Kaden-Fagt Sil'Vija
  • Lessmann Torben
  • Rau Kharal'D
  • Vegge Tomas
RU2556340C2
PRODRUGS CONTAINING INSULIN LINKER CONJUGATE 2010
  • Rau Kharal'D
  • Kleemann Feliks
  • Kherzel' Ul'Rikh
  • Kaden-Fagt Sil'Vija
  • Lessmann Torben
  • Vegge Tomas
RU2574667C2
OXADIAZOLONE DERIVATIVES AS PPAR-DELTA AGONISTS 2005
  • Kajl' Shtefani
  • Vendler Vol'Fgang
  • Glin Majke
  • Gerlittser Jokhen
  • Chandross Karen
  • Makgarri Dehniehl G.
  • Merrill Dzhin
  • Bernardelli Patrik
  • Ronan Batist
  • Terr'E Korinn
RU2374243C2
PRODRUGS CONTAINING HYALURONIC ACID CONJUGATE, LINKER AND DOUBLE AGONIST GLP-1/GLUCAGON 2016
  • Kadereit, Dieter
  • Wagner, Michael
  • Olpp, Thomas
  • Meyer, Nino
  • Dhal, Pradeep
  • Konowicz, Paul
  • Miller, Robert
  • Stefano, James
  • Besev, Magnus
  • Bossart, Martin
  • Lorenz, Katrin
  • Haack, Torsten
  • Evers, Andreas
RU2719482C2
DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS 2013
  • Radhakrishnan Balasingam
  • James Kenneth Duke
  • Vaidya Anuradha
  • Polowy Karen
RU2719579C2
PRODRUG CONTAINING A SELF-CLEAVABLE LINKER 2018
  • Kleemann, Feliks
  • Kherzel, Ulrikh
  • Kaden, Silviya
  • Rau, Kharald
  • Vegge, Tomas
RU2798085C2

RU 2 527 893 C2

Authors

Radkhakrishnan Balasingam

Aggarval Diti

Ferro Mishel'

Dzhejms Kennet D.

Malkar Navdip B.

Miller Mark A.

Pavliv Leo

Polovi Karen

Puskas Karen

Ehkvuribe Nnochiri N.

Dates

2014-09-10Published

2005-07-19Filed